InsiderClue
← All stocks

Nurix Therapeutics, Inc.

NRIX Scheduled selling only
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$186.05K
$0.00 on a plan · $186.05K straight out of an exercise
Sold at will
$0.00
0 of 3 sales
Net
−$186.05K
$0.00 against sales at will

By person

4 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
—
$149.07K (2) scheduled
−$149.07K
9,110
0.0088%
$242.67K
−63.0%
Hansen Gwenn
Chief Scientific Officer
—
$36.98K (1) scheduled
−$36.98K
117,227
0.1130%
$3.12M
+159.6%
van Houte Hans
Chief Financial Officer
—
—
—
40,166
0.0387%
$1.07M
+29.6%
GREGORY JULIA P
Director
—
—
—
10,750
0.0104%
$286.35K
—

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Ring Christine
2 Sep 2026
Chief Legal Officer
Sold after exercise
400
$26.64
$10.66K
Ring Christine
2 Sep 2026
Chief Legal Officer
Sold after exercise
5,387
$25.69
$138.42K
Hansen Gwenn
1 Sep 2026
Chief Scientific Officer
Sold after exercise
1,452
$25.47
$36.98K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 7,239
History held since 29 Jul 2020